VERZISTOBART
UNII KAC8QY6TMN

Substance Identification & Data

This profile provides standardized clinical and technical data for Verzistobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KAC8QY6TMN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2649466-18-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KAC8QY6TMN

CAS Registry Number

2649466-18-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VERZISTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162625

National Cancer Institute reference terminology for clinical and research data.

INN ID

12390

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-202

Identifier assigned by the United States Adopted Names Council.

Substance Type

Verzistobart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Verzistobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Verzistobart

Common Names & Synonyms

INCAGN 02390 [WHO-DD]

Immunoglobulin G1 [300-alanine,de-C-terminal-lysine], anti-(human T-cell immunoglobulin and mucin domain 3) (human monoclonal INCAGN02390 γ1-chain), disulfide with human monoclonal INCAGN02390 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens HAVCR2 (hepatitis A virus cellular receptor 2, T cell immunoglobulin and mucin domains family member 3, TIM3, TIM-3, TIMD3, CD366)], Homo sapiens monoclonal antibody (gamma1 heavy chain Homo sapiens (1-449) [VH (Homo sapiens IGHV3-23*04 (94.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, IGHG1v29 CH2 A84.4 (CH1 R120 (217) (121-218), hinge 1-15 (219-233), CH2 N84.4>A (300) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS K2>del (449)) (121-449)], (223-214')-disulfide with kappa light chain Homo sapiens (1'-214') [V- KAPPA (Homo sapiens IGKV3D-11*02 (96.7%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107')-Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1SV lacking the glutamine synthetase (GS-KO) gene, non-glycosylated)

VERZISTOBART [USAN]

verzistobart [INN]